The research was designed to determine the PFO closure rate, procedure-related complications, the recurrence of AF, and stroke/TIA events. Patients who underwent AS cryoablation had a significantly ...
The population of patients undergoing patent foramen ovale (PFO) closure in the US doesn’t match those of the clinical trials that formed the basis of the US Food and Drug Administration’s approval of ...
SAN FRANCISCO, CA — Using a device designed to close the patent foramen ovale (PFO) in patients who have had a cryptogenic ischemic stroke may reduce their risk of having another stroke, suggests ...
Please provide your email address to receive an email when new articles are posted on . Supraventricular arrhythmias may be underestimated in patients who have received percutaneous patent foramen ...
Jun. 17—THOMASVILLE- Archbold Interventional Cardiologist Jared Davis, MD, recently performed a cutting-edge cardiac procedure that offers treatment for a common silent heart condition that can lead ...
Efficacy Outcome: Zero recurrent strokes or TIAs were observed across all 703 patients during the four-year follow-up period. Safety Profile: Noblestitch™ exhibited a robust safety profile with no ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial septal aneurysm (ASA) is defined as excursion of the atrial septum exceeding 10 mm beyond the ...
While other device-based closures have demonstrated notable rates of atrial fibrillation (5.7–6.6%) and device-related adverse events, the NobleStitch™ system's fully suture-mediated approach ...
CHICAGO, Nov 15 (Reuters) - NMT Medical Inc's catheter system that seals a hole in the heart worked no better than drugs to prevent stroke in a study, suggesting physicians perform too many closure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback